Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Ferroptosis and cancer prognosis, Glioma Diagnosis and Treatment, Cancer-related molecular mechanisms research, and Immune cells in cancer.
Sphingosine kinase 1 promotes M2 macrophage infiltration and enhances glioma cell migration via the JAK2/STAT3 pathway
CAMK2B Impacts the Proliferation, Invasion, and Migration of Glioma Cells via the Ras/Raf/MEK/ERK Signaling Pathway
The role of ALKBH5 in regulating proliferation and invasion in U251 glioblastoma cells
Functional alterations of the brain default mode network and somatosensory system in trigeminal neuralgia
PSMC2 promotes glioma progression by regulating immune microenvironment and PI3K/AKT/mTOR pathway
Advances in Molecular Pathology, Diagnosis and Treatment of Spinal Cord Astrocytomas
Retinol dehydrogenase 10 promotes epithelial-mesenchymal transition in spinal cord gliomas via PI3K/AKT pathway
Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Radix Paeoniae Rubra Against Glioma
Comprehensive pan-cancer analysis of ACSS3 as a biomarker for prognosis and immunotherapy response
CAMK2B affects the proliferation, invasion and migration of glioma cells via Ras/Raf/MEK/ERK signal pathway
Arylsulfatase D is a prognostic biomarker that promotes glioma cells progression through JAK2/STAT3 pathway and M2 macrophage infiltration
STEAP3 is a prognostic biomarker that promotes glioma progression by regulating immune microenvironment and PI3K-AKT pathway
Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Radix Paeoniae Rubra Against Glioma
Procollagen C-protease enhancer protein is a prognostic factor for glioma and promotes glioma development by regulating multiple tumor-related pathways and immune microenvironment
The application of magnetic resonance imaging (MRI) for the prediction of surgical outcomes in trigeminal neuralgia
Predictive potential of STEAP family for survival, immune microenvironment and therapy response in glioma